Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹935.6 Cr 7.4% -3.6% -33.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹107,075.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 2.2% -1.6% 0% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

7.4%

-3.6%

-33.5%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses